Luke O'Neill
Director/Board Member at POOLBEG PHARMA PLC
Luke O'Neill active positions
| Companies | Position | Start | End |
|---|---|---|---|
| POOLBEG PHARMA PLC | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| European Molecular Biology Organization | Corporate Officer/Principal | 2004-12-31 | - |
Inflazome Ltd.
 Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Director/Board Member | 2015-12-31 | - |
| Chief Tech/Sci/R&D Officer | 2015-12-31 | - | |
| Founder | 2015-12-31 | - | |
| Trinity Biomedical Sciences Institute | Corporate Officer/Principal | - | - |
| Royal Irish Academy | Corporate Officer/Principal | - | - |
Career history of Luke O'Neill
Former positions of Luke O'Neill
| Companies | Position | Start | End |
|---|---|---|---|
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Founder | - | - |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
| Chief Tech/Sci/R&D Officer | 2023-01-11 | - | |
| Trinity College Dublin | Corporate Officer/Principal | 2007-12-31 | - |
Training of Luke O'Neill
| University of London | Doctorate Degree |
Statistics
International
| Ireland | 5 |
| United Kingdom | 4 |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| POOLBEG PHARMA PLC | Health Technology |
| Private companies | 5 |
|---|---|
| European Molecular Biology Organization | |
| Trinity Biomedical Sciences Institute | |
Inflazome Ltd.
Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Health Technology |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Luke O'Neill
- Experience
